Author

S. K. Anderson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:spatial domain detection· 3 Research Focus:host-pathogen & immune response· 2 Assay:imaging· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. L. Wink· 4 shared D. A. Wink· 4 shared D. Butcher· 4 shared D. W. McVicar· 4 shared E. F. Edmondson· 4 shared M. Pore· 4 shared S. Ambs· 4 shared S. J. Lockett· 4 shared

Activity by Year

2022-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

A. L. Wink

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients

L. A. Ridnourl, R. Y. Cheng, W. F. Heinz, M. Pore, A. L. Gonzalez, E. L. Femino, R. Moffat, A. L. Wink, F. Imtiaz, L. Coutinho, D. Butcher, E. F. Edmondson, C. Rangel, S. T. Wong, S. Lipkowitz, , D. A. Wink

The paper identifies spatial interactions between NOS2, COX2, and T-effector cells in ER- breast cancer, linking these patterns to poor patient outcomes and suggesting potential therapeutic strategies.

bioRxiv · Dec 21, 2023 · PreprintCancer Biology

NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast Cancer

L. A. Ridnourl, W. F. Heinz, R. Y. Cheng, A. L. Wink, N. Kedei, M. Pore, F. Imtiaz, E. L. Femino, A. L. Gonzalez, L. Coutinho, D. Butcher, E. F. Edmondson, C. Rangel, R. J. Kinders, S. Lipkowitz, , D. A. Wink

This study identifies NOS2 and COX2 as key spatial targets in ER- breast cancer that influence immune phenotypes and clinical outcomes through spatial analysis of tumor microenvironments.

bioRxiv · Dec 21, 2023 · PreprintCancer Biology

Interferon-gamma is Quintessential for NOS and COX Expression in ER- Breast Tumors that Lead to Poor Outcome

R. Y. Cheng, L. A. Ridnourl, A. L. Wink, A. L. Gonzalez, E. L. Femino, H. Rittscher, V. Somasundarum, W. F. Heinz, L. Coutinho, C. Rangel, E. f. Edmondson, D. Butcher, R. J. Kinders, X. Li, S. T. Wong, , D. A. Wink

The paper shows IFN-gamma induces NOS2 and COX2 in ER-breast tumors, linked to poor outcomes, through spatial analysis of tumor microenvironments.

bioRxiv · Apr 6, 2023Cancer Biology

NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+ T Cell Spatial Orientation and Density

V. Somasundaram, L. A. Ridnour, R. Y. S. Cheng, A. J. Walke, N. Kedei, D. D. Bhattacharyya, A. L. Wink, E. F. Edmondson, D. Butcher, A. Warner, T. H. Dorsey, D. A. Scheiblin, W. Heinz, R. J. Bryant, R. Kinders, , D. A. Wink

This paper shows that blocking NOS2 and COX2 reduces TNBC tumor growth and improves CD8+ T cell infiltration and spatial distribution in tumors.

bioRxiv · Jun 3, 2022 · PreprintCancer Biology